User profiles for Christopher M. Booth

Christopher M. Booth MD FRCPC

Professor of Oncology, Queen's University
Verified email at kgh.kari.net
Cited by 18844

Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area

CM Booth, LM Matukas, GA Tomlinson, AR Rachlis… - Jama, 2003 - jamanetwork.com
ContextSevere acute respiratory syndrome (SARS) is an emerging infectious disease that
first manifested in humans in China in November 2002 and has subsequently spread …

Mortality due to cancer treatment delay: systematic review and meta-analysis

…, GA Paulin, E Harvey-Jones, DE O'Sullivan, CM Booth… - bmj, 2020 - bmj.com
Objective To quantify the association of cancer treatment delay and mortality for each four
week increase in delay to inform cancer treatment pathways. Design Systematic review and …

Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis

…, WJ Mackillop, W Kong, WD King, CM Booth - Jama, 2011 - jamanetwork.com
Context Adjuvant chemotherapy (AC) improves survival among patients with resected
colorectal cancer. However, the optimal timing from surgery to initiation of AC is unknown. …

[HTML][HTML] Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic

TP Hanna, GA Evans, CM Booth - Nature reviews Clinical oncology, 2020 - nature.com
During the COVID-19 global pandemic, the cancer community faces many difficult questions.
We will first discuss safety considerations for patients with cancer requiring treatment in …

Is this patient dead, vegetative, or severely neurologically impaired?: assessing outcome for comatose survivors of cardiac arrest

CM Booth, RH Boone, G Tomlinson, AS Detsky - Jama, 2004 - jamanetwork.com
ContextMost survivors of cardiac arrest are comatose after resuscitation, and meaningful
neurological recovery occurs in a small proportion of cases. Treatment can be lengthy, …

[HTML][HTML] Priorities for cancer research in low-and middle-income countries: a global perspective

CS Pramesh, RA Badwe, N Bhoo-Pathy, CM Booth… - Nature medicine, 2022 - nature.com
Cancer research currently is heavily skewed toward high-income countries (HICs), with little
research conducted in, and relevant to, the problems of low- and middle-income countries (…

Cancer in sub-Saharan Africa: a lancet oncology commission

…, S Avery, P Barango, N Bih, CM Booth… - The Lancet …, 2022 - thelancet.com
In sub-Saharan Africa (SSA), urgent action is needed to curb a growing crisis in cancer
incidence and mortality. Without rapid interventions, data estimates show a major increase in …

The impact of socioeconomic status on stage of cancer at diagnosis and survival: a population‐based study in Ontario, Canada

CM Booth, G Li, J Zhang‐Salomons, WJ Mackillop - Cancer, 2010 - Wiley Online Library
BACKGROUND: Lower socioeconomic status (SES) is associated with worsened cancer
survival. The authors evaluate the impact of SES on stage of cancer at diagnosis and survival in …

Guideline on muscle-invasive and metastatic bladder cancer (European Association of Urology guideline): American Society of Clinical Oncology clinical practice …

MI Milowsky, RB Rumble, CM Booth… - Journal of clinical …, 2016 - ascopubs.org
Purpose To endorse the European Association of Urology guideline on muscle-invasive (MIBC)
and metastatic bladder cancer. The American Society of Clinical Oncology (ASCO) has …

Evolution of the randomized clinical trial in the era of precision oncology

…, EA Eisenhauer, V Prasad, B Gyawali, CM Booth - JAMA …, 2021 - jamanetwork.com
Importance The randomized clinical trial (RCT) in oncology has evolved since its widespread
adoption in the 1970s. In recent years, concerns have emerged regarding the use of …